Long-Lasting Disease Stabilization in the Absence of Toxicity in Metastatic Lung Cancer Patients Vaccinated With an HLA-A2-restricted Epitope Derived From Indoleamine 2,3 Dioxygenase

Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/2051-1426-1-s1-p273
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Indoleamine 2,3-Dioxygenase as a Prognostic Factor in Patients With Non-Small Cell Lung Cancer

Journal of Clinical & Cellular Immunology
2014English

A HLA-A2-restricted CTL Epitope Induces Anti-Tumor Effects Against Human Lung Cancer in Mouse Xenograft Model

Oncotarget
Oncology
2015English

Indoleamine 2,3-Dioxygenase 1 (IDO1)

Science-Business eXchange
2012English

Indole Peroxygenase Activity of Indoleamine 2,3-Dioxygenase

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2012English

Advances in Indoleamine 2,3-Dioxygenase 1 Medicinal Chemistry

MedChemComm
Organic ChemistryMolecular MedicinePharmacologyBiochemistryPharmaceutical ScienceDrug Discovery
2017English

Identification of a Novel HLA-A24-restricted Cytotoxic T Lymphocyte Epitope Peptide Derived From Mesothelin in Pancreatic Cancer

Oncotarget
Oncology
2018English

Inhibition of Experimental Asthma by Indoleamine 2,3-Dioxygenase

Journal of Clinical Investigation
Medicine
2004English

Induction of Pulmonary Indoleamine 2,3-Dioxygenase by Interferon.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1981English

Decreased Indoleamine 2,3-Dioxygenase Activity and IL-10/IL-17A Ratio in Patients With COPD

Thorax
PulmonaryRespiratory Medicine
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy